Summit Tx Capital, L.P. Vera Therapeutics, Inc. Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q2 2025
A detailed history of Summit Tx Capital, L.P. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 87,653 shares of VERA stock, worth $2.6 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
87,653
Previous 128,579
31.83%
Holding current value
$2.6 Million
Previous $3.09 Billion
33.13%
% of portfolio
0.09%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
199Shares Held
64.6MCall Options Held
1.58MPut Options Held
365K-
Avoro Capital Advisors LLC New York, NY6.3MShares$187 Million2.71% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.48MShares$133 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.43MShares$101 Million9.64% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.35MShares$99.1 Million1.81% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$98.8 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $801M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...